$162.81 +0.13 (%) Amgen Inc - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. #PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates Chaos In New York

    Benzinga | Nov. 19, 2014 | 07:50AM EST
  2. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  3. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  4. Amgen Shares Consolidating Ahead Of More Gains?

    Benzinga | Nov. 13, 2014 | 13:25PM EST
  5. UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New Drugs

    Benzinga | Nov. 12, 2014 | 09:17AM EST
  6. Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis

    Benzinga | Nov. 11, 2014 | 16:03PM EST
  7. Big Cap 20 Stuffed With Medical Names

    IBD | Nov. 10, 2014 | 19:34PM EST
  8. Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble

    Benzinga | Nov. 4, 2014 | 16:30PM EST
  9. AbbVie Beats Q3 Earnings Estimates, Raises Guidance

    IBD | Oct. 31, 2014 | 14:25PM EST
  10. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  11. Stocks Trim Losses After Fed Report; Solarwinds Soars

    IBD | Oct. 29, 2014 | 16:22PM EST
  12. UPDATE: Nomura Upgrades Amgen

    Benzinga | Oct. 29, 2014 | 11:42AM EST
  13. Amgen resists pressure to split

    IBD | Oct. 28, 2014 | 18:43PM EST
  14. Amgen: Stronger Drug Portfolio with Acquisition

    GuruFocus | Oct. 28, 2014 | 15:34PM EST
  15. Amgen Refuses To Split, But Plans Hearten Investors

    IBD | Oct. 28, 2014 | 14:18PM EST
  16. Amgen At All-Time High, Deutsche Bank Ups Price Target

    Benzinga | Oct. 28, 2014 | 13:33PM EST
  17. Stocks Extend Gains As Alibaba, Tesla Rally

    IBD | Oct. 28, 2014 | 12:04PM EST
  18. Stocks Launch In Climbing Mood; Amgen, Spirit Airlines Climbing

    IBD | Oct. 28, 2014 | 10:36AM EST
  19. Amgen Rallies 3% After Announcing Growth And Capital Plans

    Benzinga | Oct. 28, 2014 | 09:32AM EST
  20. Four Biotechs Lead Health Care Stocks In Big Cap 20

    IBD | Oct. 27, 2014 | 19:00PM EST
  21. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  22. Amgen Earnings Clear Views

    IBD | Oct. 27, 2014 | 18:49PM EST
  23. Amgen Beats Q3 Earnings Estimates

    Benzinga | Oct. 27, 2014 | 17:16PM EST
  24. Twitter Off, Amgen, Buffalo Wild Wings Up After Hours

    IBD | Oct. 27, 2014 | 17:04PM EST
  25. Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500

    IBD | Oct. 27, 2014 | 15:00PM EST
  26. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  27. Earnings Scheduled For October 27, 2014

    Benzinga | Oct. 27, 2014 | 05:06AM EST
  28. Keep an Eye on These 7 Stocks for October 27, 2014

    Benzinga | Oct. 27, 2014 | 04:21AM EST
  29. Stocks Put End To Four-Week Slide

    IBD | Oct. 24, 2014 | 16:56PM EST
  30. Fast Money Picks For October 23

    Benzinga | Oct. 23, 2014 | 07:00AM EST
  31. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  32. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD | Oct. 22, 2014 | 17:01PM EST
  33. Daniel Loeb Comments on Amgen Inc

    GuruFocus | Oct. 22, 2014 | 12:06PM EST
  34. Third Point Q3 2014 Investor Letter

    GuruFocus | Oct. 22, 2014 | 10:24AM EST
  35. Markets In Rally Mode: S&P 500 And Nasdaq Surge As Dow Lags

    Benzinga | Oct. 21, 2014 | 16:41PM EST
  36. Third Point's Notable Additions And Exit: Alibaba, eBay, Sony

    Benzinga | Oct. 21, 2014 | 15:38PM EST
  37. Stocks To Watch For October 20, 2014

    Benzinga | Oct. 20, 2014 | 04:43AM EST
  38. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  39. Regeneron's Eylea Tops Rivals

    IBD | Oct. 17, 2014 | 18:45PM EST
  40. Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors

    Benzinga | Oct. 17, 2014 | 16:20PM EST
  41. Regeneron Eye Drug Beats Rivals While Amgen Sues

    IBD | Oct. 17, 2014 | 11:27AM EST
  42. Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement

    Benzinga | Oct. 17, 2014 | 09:01AM EST
  43. Most Top Industry Groups Fall Harder Than Market

    IBD | Oct. 10, 2014 | 17:58PM EST
  44. UPDATE: Amgen's BiTE Received FDA Priority Review Designation

    Benzinga | Oct. 9, 2014 | 16:06PM EST
  45. Illumina Pads Gene Sequencing Lead With Pharma Deals

    IBD | Oct. 8, 2014 | 16:04PM EST
  46. Some Old Stocks Still Have Young Legs

    IBD | Oct. 6, 2014 | 18:47PM EST
  47. Amgen, Inc. Showing Strong Performance Despite Low Beta

    Benzinga | Sep. 30, 2014 | 12:06PM EST
  48. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD | Sep. 24, 2014 | 13:27PM EST
  49. Most Big Cap 20 Stocks Near Entries, But Risks Exist

    IBD | Sep. 22, 2014 | 19:05PM EST
  50. These 3 Biotech Stocks Just Hit New Highs

    Benzinga | Sep. 22, 2014 | 13:31PM EST
Trading Center